King Pharma (Weighted Average Cost of Capital (WACC) Analysis)
 Improve your investment analysis with by seeing the King Pharma's Discounted Cash Flow analysis, King Pharma's Warren Buffet analysis, and King Pharma's Comparable Multiple analysis.  Helpful Information for King Pharma's AnalysisWhat is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine King Pharma's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for King Pharma. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in King Pharma before they make value investing decisions. This WACC analysis is used in King Pharma's discounted cash flow (DCF) valuation and see how the WACC calculation affect's King Pharma's company valuation. |
WACC Analysis Information1. The WACC (discount rate) calculation for King Pharma uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for King Pharma over the long term. If there are any short-term differences between the industry WACC and King Pharma's WACC (discount rate), then King Pharma is more likely to revert to the industry WACC (discount rate) over the long term. 2. The WACC calculation uses the higher of King Pharma's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and King Pharma uses a significant proportion of equity capital. |
